risk-adapted turbt
Published 1 year ago • 1.1K plays • Length 20:13Download video MP4
Download video MP3
Similar videos
-
14:13
point-counterpoint: muscle invasive bladder cancer–trimodal therapy perspective
-
24:32
bladder sparing tri-modal therapy updates
-
26:18
controversies in non-muscle invasive bladder cancer (nmibc): guidelines and beyond 2023
-
8:37
turbt for bladder cancer
-
13:26
radiation oncology perspective: image-guided metastasis-directed therapy
-
3:28
bladder tumor removal with turbt - urology care foundation
-
14:46
enhanced techniques of non-muscle invasive bladder cancer detection
-
11:40
point-counterpoint: muscle invasive bladder cancer–cystectomy perspective
-
21:10
prioritizing the optimal therapy for t1 bladder cancer: using the old and new
-
13:23
updating the definitions, endpoints, and clinical trial designs for bladder cancer
-
53:01
ucsf urology grand rounds april 10, 2024
-
44:13
rethinking turbt: optimizing turbt to improve outcomes of nmibc
-
17:42
bladder-sparing trimodality therapy
-
13:59
en bloc turb: more than a safe and feasible surgical technique
-
21:27
quality indicators in radical cystectomy
-
11:44
bladder cancer risk stratification: moving from the old to the new
-
23:44
a review of aua/suo/astro guidelines for muscle invasive bladder cancer (mibc)
-
18:56
robotic cystectomy and icud for muscle-invasive bladder cancer
-
9:12
immunotherapy for nmibc: emerging and expanding indications
-
10:04
there is a role for biomarkers/genomics in the risk stratification of prostate cancer